Literature DB >> 30118917

How to improve clinical practice on forced medication in psychiatric practice: Suggestions from the EUNOMIA European multicentre study.

Mario Luciano1, Corrado De Rosa1, Gaia Sampogna1, Valeria Del Vecchio1, Vincenzo Giallonardo1, Michele Fabrazzo1, Francesco Catapano1, George Onchev2, Jiri Raboch3, Anastasia Mastrogianni4, Zahava Solomon5, Algirdas Dembinskas6, Petr Nawka7, Andrzej Kiejna8, Francisco Torres-Gonzales9, Lars Kjellin10, Thomas Kallert11, Andrea Fiorillo12.   

Abstract

BACKGROUND: The decision to adopt forced medication in psychiatric care is particularly relevant from a clinical and ethical viewpoint. The European Commission has funded the EUNOMIA study in order to develop European recommendations for good clinical practice on coercive measures, including forced medication.
METHODS: The recommendations on forced medication have been developed in 11 countries with the involvement of national clinical leaders, key-professionals and stakeholders' representatives. The national recommendations have been subsequently summarized into a European shared document.
RESULTS: Several cross-national differences exist in the use of forced medication. These differences are mainly due to legal and policy making aspects, rather than to clinical situations. In fact, countries agreed that forced medication can be allowed only if the following criteria are present: 1) a therapeutic intervention is urgently needed; 2) the voluntary intake of medications is consistently rejected; 3) the patient is not aware of his/her condition. Patients' dignity, privacy and safety shall be preserved at all times.
CONCLUSION: The results of our study show the need of developing guidelines on the use of forced medication in psychiatric practice, that should be considered as the last resort and only when other therapeutic option have failed.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Coercive measures; Forced medication; Procedures; Recommendation

Mesh:

Substances:

Year:  2018        PMID: 30118917     DOI: 10.1016/j.eurpsy.2018.07.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

1.  Trends in the use of coercive measures in Finnish psychiatric hospitals: a register analysis of the past two decades.

Authors:  Maritta Välimäki; Min Yang; Tero Vahlberg; Tella Lantta; Virve Pekurinen; Minna Anttila; Sharon-Lise Normand
Journal:  BMC Psychiatry       Date:  2019-07-26       Impact factor: 3.630

2.  Factors associated with involuntary admissions: a register-based cross-sectional multicenter study.

Authors:  G Maina; G Rosso; C Carezana; E Mehanović; F Risso; V Villari; L Gariglio; M Cardano
Journal:  Ann Gen Psychiatry       Date:  2021-01-07       Impact factor: 3.455

3.  Effects of Recovery-Orientation on the Use of Forced Medication and Maximum Daily Drug Dose: The "Weddinger Modell".

Authors:  Klara Czernin; Felix Bermpohl; Alexandre Wullschleger; Lieselotte Mahler
Journal:  Front Psychiatry       Date:  2021-12-15       Impact factor: 4.157

4.  A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Authors:  Michele Fabrazzo; Salvatore Cipolla; Simona Signoriello; Alessio Camerlengo; Giulia Calabrese; Giulia Maria Giordano; Giuseppe Argenziano; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2021-11-25       Impact factor: 5.361

5.  An Evidence-Based Educational Intervention for Reducing Coercive Measures in Psychiatric Hospitals: A Randomized Clinical Trial.

Authors:  Maritta Välimäki; Tella Lantta; Minna Anttila; Tero Vahlberg; Sharon-Lise Normand; Min Yang
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Aims to Reduce Coercive Measures in Forensic Inpatient Treatment: A 9-Year Observational Study.

Authors:  Steffen Lau; Nathalie Brackmann; Andreas Mokros; Elmar Habermeyer
Journal:  Front Psychiatry       Date:  2020-05-27       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.